EUVIMEDEUVIMED entdecken
Open Access

IFI16 /204 Promotes Dendritic Cell Activation and Anti‐Hepatocellular Carcinoma Efficacy via the STING – TBK1 – IRF3 Signalling Pathway

Long Zhang, Wenjing He, Hanyuan Zhang iD, Xuzhi Zhang, Hanyu Wang, Shuai Wang, Xinyi Li, Yifang Gao, Yi Ma iD

Immunology · 2026-09 · 179 (1) · 72-85

DOI: 10.1111/imm.70152 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunology, online erschienen am 17.05.2026. Verfasst von Long Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Organ Transplantation, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Interferon Regulatory Factor-3, Liver Neoplasms, Dendritic Cells, Carcinoma, Hepatocellular. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Natural Science Foundation of Guangdong Province, National Natural Science Foundation of China, Science and Technology Planning Project of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

IFI16 (the murine homologue is IFI204) is an intracellular double‐stranded DNA (dsDNA) pattern recognition receptor (PRR) that plays a crucial role in bridging innate and adaptive immunity. However, its function in dendritic cell (DC) activation and anti‐hepatocellular carcinoma (HCC) efficacy remains poorly characterised. This study demonstrates that IFI16 promotes DC maturation, functional activation and antitumor immunity. This effect occurs through activation of the STING–TBK1–IRF3 signalling pathway. Our findings establish IFI16 as a key molecule enabling DCs to sense dsDNA and initiate antitumor responses. Consequently, targeting IFI16 and its downstream STING–TBK1–IRF3 signalling pathway represents a potential therapeutic strategy for hepatocellular carcinoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interferon Regulatory Factor-3Liver NeoplasmsDendritic CellsCarcinoma, HepatocellularMembrane ProteinsProtein Serine-Threonine KinasesPhosphoproteinsNuclear ProteinsAnimalsSignal TransductionHumansSTING ProteincGAS-STING Signaling PathwayMiceCell Line, TumorMice, Inbred C57BLInnate Immunity Recognition

Stichwörter der Autor:innen

IFI16IFI204STINGhepatocellular carcinomapattern recognition receptortumour immunology

Substanzen

Interferon Regulatory Factor-3Membrane ProteinsProtein Serine-Threonine KinasesPhosphoproteinsSTING ProteinNuclear ProteinsIfi16 protein, mouseSting1 protein, mouseIFI16 protein, humanTbk1 protein, mouse

Autor:innen und Institutionen

  • Department of Organ Transplantation, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Guangdong Provincial Key Laboratory of Organ Donation and Transplant Immunology, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Guangdong Provincial International Cooperation Base of Science and Technology (Organ Transplantation), the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
  • School of Nursing, Sun Yat-Sen University, Guangzhou, Guangdong Province, China.

ORCID-Profile: Hanyuan Zhang, Yi Ma

Förderung

  • Natural Science Foundation of Guangdong Province
  • National Natural Science Foundation of China
  • Science and Technology Planning Project of Guangdong Province
  • Guangzhou Municipal Science and Technology Project
  • Guangdong Provincial Key Laboratory Construction Projection on Organ Donation and Transplant Immunology
  • Guangdong Provincial International Cooperation Base of Science and Technology (Organ Transplantation)

Zitieren

APA

Zhang, L., He, W., Zhang, H., Zhang, X., Wang, H., Wang, S., Li, X., Gao, Y., & Ma, Y. (2026). IFI16 /204 Promotes Dendritic Cell Activation and Anti‐Hepatocellular Carcinoma Efficacy via the STING – TBK1 – IRF3 Signalling Pathway. Immunology, 179(1), 72-85. https://doi.org/10.1111/imm.70152

Vancouver

Zhang L, He W, Zhang H, Zhang X, Wang H, Wang S, et al. IFI16 /204 Promotes Dendritic Cell Activation and Anti‐Hepatocellular Carcinoma Efficacy via the STING – TBK1 – IRF3 Signalling Pathway. Immunology. 2026;179(1):72-85. doi:10.1111/imm.70152

BibTeX
@article{Zhang2026,
  author = {Zhang, Long and He, Wenjing and Zhang, Hanyuan and Zhang, Xuzhi and Wang, Hanyu and Wang, Shuai and Li, Xinyi and Gao, Yifang and Ma, Yi},
  title = {IFI16 /204 Promotes Dendritic Cell Activation and Anti‐Hepatocellular Carcinoma Efficacy via the STING – TBK1 – IRF3 Signalling Pathway},
  journal = {Immunology},
  year = {2026},
  volume = {179},
  number = {1},
  pages = {72--85},
  doi = {10.1111/imm.70152}
}
Kostenlos starten →